Description
Retatrutide (LY3437943) is a next-generation triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. It represents the cutting edge of metabolic research compounds.
Research Applications
- Metabolic syndrome and obesity research
- Insulin sensitivity studies
- Lipid metabolism research
- Cardiovascular risk factor research
Product Specifications
- Purity: 99%+ (HPLC verified)
- Form: Lyophilized powder
- Storage: Refrigerate; stable 12 months frozen
For research and laboratory use only. Not intended for human or animal consumption.








Reviews
There are no reviews yet.